Tuesday, April 21, 2020 2:34:00 PM
Post by CaptainANZAC on Hot Copper explains the mechanics:
There is a lot of incorrect commentary on what this means but that is not surprising since dual listings are not that common, and poorly understood.
Here is the crux of it: it is not a 1:5 reverse split. It is a 1:100 reverse split. Shares outstanding will reduce from 2.1 billion (yikes) to 21 million which is pretty much what you see on NASDAQ for company's at this stage. CDI's on ASX will trade at ratio of 5 CDIs to every 1 share of common stock traded on NASDAQ. So, what does this mean?
For ASX holders you have to get the number of shares you hold (say 5,000) then divide that by 100 (for the reverse split (to give you 50 shares of common stock)) then multiple that by 5 (for the 5:1 ASX to NASDAQ ratio mentioned above) such that you will now own 250 CDIs. In other words, when you divide your holding by 100 and then multiple 5 it is mathematically the same as dividing your initial holding by 20!
For NASDAQ holders you get your ADR holding (say 250) and multiply it by 20 (to get you back to the number of ordinary shares you hold given ADR's presently trade on the basis of 20 ordinary shares for 1 share of common stock) to get to 5,000 ordinary shares and then I divide that number by 100 (being the reverse split) to get to 50 shares of common stock which is what I will have on NASDAQ afterwards. In other words, multipling my current ADR holding by 20 and then dividing by 100 is mathematically the same as dividing my ADR holding by 5 to get to my future common stock holding on NASDAQ.
Secondly, trading is completely unchanged (other than the reverse split). The only difference is that you will need to cast your votes at shareholders meeting via CHESS Nominees exactly like many shareholders who hold through nominees or custodians like NAB or HSBC do today.
Lastly, here is ECONOMICS 101: value is independent of capital structure. Google it. So the run off today is a lot of idiot day traders. As for indexing issues... come on ... do we Australians think the indexes are bigger and more numerous here in OZ versus the world's largest capital market. Can anyone spell parochialism?
Recent RCEL News
- AVITA Medical to Announce First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/15/2024 09:05:00 PM
- AVITA Medical Updates Expected First Quarter 2024 Revenue • GlobeNewswire Inc. • 04/10/2024 09:11:25 PM
- AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement • GlobeNewswire Inc. • 02/29/2024 09:02:00 PM
- AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/29/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 02/23/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:02:06 PM
- AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/01/2024 09:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:05:12 PM
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific • GlobeNewswire Inc. • 01/10/2024 09:01:00 PM
- AVITA Medical Announces Preliminary 2023 Financial Highlights, Provides 2024 Financial Guidance and Business Update • GlobeNewswire Inc. • 01/10/2024 02:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:51:10 PM
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2024 02:00:00 PM
- AVITA Medical to Host Investor Webinar Briefing • GlobeNewswire Inc. • 12/04/2023 02:00:00 PM
- AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference • GlobeNewswire Inc. • 11/21/2023 09:15:00 PM
- Keep An Eye Out: Pre-Market Movers And Analyst Recommendations • IH Market News • 11/21/2023 02:10:28 PM
- AVITA Medical Updates Full Year 2023 Guidance • GlobeNewswire Inc. • 11/20/2023 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:09:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:07:10 PM
- AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year • GlobeNewswire Inc. • 11/09/2023 09:01:00 PM
- AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe • GlobeNewswire Inc. • 11/09/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:36:53 PM
- AVITA Medical to Announce Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 10/19/2023 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 01:07:51 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM